Literature DB >> 9024263

Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma.

E Davies1, A Bonnardeaux, P F Plouin, P Corvol, E Clauser.   

Abstract

Angiotensin II stimulates aldosterone secretion from the adrenal zona glomerulosa and mediates most of its biological effects via G protein-coupled type 1 angiotensin II receptors (AT1). A number of G protein-coupled receptors are constitutively activated as a result of somatic mutations in the gene encoding the protein. It is, therefore, possible that primary hyperaldosteronism caused by an aldosterone-producing adenoma (APA) may be the result of constitutive activation of the AT1 receptor. The 1.1-kilobase coding region (exon 5) of the AT1 receptor gene was analyzed in APA and normal adrenal tissue for the presence of mutations using single stranded conformational polymorphism and sequencing techniques. In 17 APAs, no functional mutations were found that could account for the observed pathophysiology. However, three silent polymorphisms were detected in regions encoding the second extracellular loop, the intracellular arm preceding the COOH terminal, and the 3'-untranslated region. In conclusion, somatic mutations in the coding region of the AT1 receptor gene do not appear to play a role in primary hyperaldosteronism caused by an APA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9024263     DOI: 10.1210/jcem.82.2.3764

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay.

Authors:  C Parnot; S Bardin; S Miserey-Lenkei; D Guedin; P Corvol; E Clauser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

Review 2.  Primary aldosteronism: rare bird or common cause of secondary hypertension?

Authors:  M Stowasser
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  Expression of potassium channel isoforms mRNA in normal human adrenals and aldosterone-secreting adenomas.

Authors:  R Sarzani; F Pietrucci; M Francioni; F Salvi; C Letizia; E D'Erasmo; P Dessì Fulgheri; A Rappelli
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

Review 4.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

5.  AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II.

Authors:  Raphael Rozenfeld; Achla Gupta; Khatuna Gagnidze; Maribel P Lim; Ivone Gomes; Dinah Lee-Ramos; Natalia Nieto; Lakshmi A Devi
Journal:  EMBO J       Date:  2011-05-03       Impact factor: 11.598

Review 6.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

7.  Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice.

Authors:  Sandrine Billet; Sabine Bardin; Sonia Verp; Véronique Baudrie; Annie Michaud; Sophie Conchon; Martine Muffat-Joly; Brigitte Escoubet; Evelyne Souil; Ghislaine Hamard; Kenneth E Bernstein; Jean Marie Gasc; Jean-Luc Elghozi; Pierre Corvol; Eric Clauser
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

8.  Angiotensin II receptor 1 gene variants are associated with high-altitude pulmonary edema risk.

Authors:  Tianbo Jin; Yongchao Ren; Xikai Zhu; Xun Li; Yongri Ouyang; Xue He; Zhiying Zhang; Yuan Zhang; Longli Kang; Dongya Yuan
Journal:  Oncotarget       Date:  2016-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.